Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
US Army
Fish and Richardson
Cipla
Teva
Citi
Daiichi Sankyo
McKinsey
Deloitte

Generated: December 10, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR INSULATARD NPH HUMAN

« Back to Dashboard

Clinical Trials for Insulatard Nph Human

Trial ID Title Status Sponsor Phase Summary
NCT00346996 Insulin Analogues and Severe Hypoglycaemia Completed Novo Nordisk A/S Phase 4 Severe hypoglycaemia is hampering the lives of many diabetic patients. The effect on the occurrence of severe hypoglycaemia during two different insulin regimens are to be investigated. In total, 250 hypoglycaemia prone type 1 diabetic patients will be randomised to receive analogue and human insulin for one year in random order. Outcomes will be number of episodes of severe hypoglycaemia
NCT00346996 Insulin Analogues and Severe Hypoglycaemia Completed Lise Tarnow Phase 4 Severe hypoglycaemia is hampering the lives of many diabetic patients. The effect on the occurrence of severe hypoglycaemia during two different insulin regimens are to be investigated. In total, 250 hypoglycaemia prone type 1 diabetic patients will be randomised to receive analogue and human insulin for one year in random order. Outcomes will be number of episodes of severe hypoglycaemia
NCT00566124 Basal Insulins - Pharmacodynamics Completed Novo Nordisk A/S Phase 4 To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Insulatard Nph Human

Condition Name

Condition Name for Insulatard Nph Human
Intervention Trials
Diabetes 7
Diabetes Mellitus, Type 2 4
Type 1 Diabetes 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Insulatard Nph Human
Intervention Trials
Diabetes Mellitus 8
Diabetes Mellitus, Type 2 6
Diabetes Mellitus, Type 1 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Insulatard Nph Human

Trials by Country

Trials by Country for Insulatard Nph Human
Location Trials
Denmark 3
Germany 2
Romania 1
Austria 1
Hungary 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Insulatard Nph Human

Clinical Trial Phase

Clinical Trial Phase for Insulatard Nph Human
Clinical Trial Phase Trials
Phase 4 5
Phase 2 1
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Insulatard Nph Human
Clinical Trial Phase Trials
Completed 10
Unknown status 2
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Insulatard Nph Human

Sponsor Name

Sponsor Name for Insulatard Nph Human
Sponsor Trials
Novo Nordisk A/S 8
Rigshospitalet, Denmark 1
University of Aarhus 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Insulatard Nph Human
Sponsor Trials
Other 10
Industry 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Chinese Patent Office
Colorcon
Daiichi Sankyo
Deloitte
Farmers Insurance
Federal Trade Commission
AstraZeneca
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.